Aytu BioPharma Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun 2025Jun 2024Jun 2023Jun 2022Jun 2021
Valuation Ratios
P/S Ratio0.290.270.120.281.92
P/B Ratio1.030.630.230.600.92
Enterprise Value Ratios
EV/Revenue0.360.250.200.211.61
EV/EBITDA3.022.245.92
EV/EBIT9.4328.87
Profitability & Returns
Return on Equity (ROE)-0.61%-0.37%-0.18%-1.20%-0.50%
Return on Assets (ROA)0.01%0.00%-0.02%-0.12%-0.11%
Return on Capital Employed (ROCE)0.04%0.01%-0.08%-0.52%-0.24%
Leverage & Solvency Ratios
Debt/Equity1.210.590.470.410.18
Debt/EBITDA2.681.754.68
Liquidity Ratios
Current Ratio1.260.991.030.930.96
Quick Ratio0.980.700.750.640.71
Efficiency Ratios
Asset Turnover0.550.510.540.480.31
Inventory Turnover1.741.562.233.412.77
Yield & Distribution Ratios
Earnings Yield-0.69%-0.91%-1.93%-4.09%-0.46%
FCF Yield-0.11%-0.10%-0.58%-1.08%-0.22%
Buyback Yield-0.13%-0.66%-1.27%-0.76%-2.71%